DarioHealth Corp expected to post a loss of $1.21 a share - Earnings Preview

DarioHealth

07/08/2026 18:37

DarioHealth Corp DRIO.OQ DRIO.O is expected to  show a rise in quarterly revenue when it reports  results on August 11 for the period ending June 30 2026
The New York City-based  company is expected to report a 10.3% increase in revenue to $5.923 million from $5.37 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
​LSEG's mean analyst estimate for DarioHealth Corp is for a loss of $1.21 per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for DarioHealth Corp is $11.50, about 48.4% above its last closing price of $7.75
This summary was machine generated August 7 at 17:37 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)